Search Results for keywords:"National Center for Complementary

The U.S. Department of Health and Human Services (HHS) Office of Minority Health is requesting information from American Indian and Alaska Native tribes and organizations to help develop a new Center for Indigenous Innovation and Health Equity. The Center aims to improve health for these communities by focusing on research, education, services, and health policy development. Input is sought to shape the Center's objectives and ensure it effectively addresses health disparities. Responses are due by March 14, 2021, and can be submitted online or via email.

The U.S. Department of Health and Human Services (HHS) Office of Minority Health is seeking feedback from Native Hawaiian and Pacific Islander (NHPI) communities and organizations to help develop a new Center for Indigenous Innovation and Health Equity. This center aims to improve health outcomes by focusing on indigenous public health strategies for American Indian, Alaska Native, Native Hawaiian, and Pacific Islander populations. Feedback is requested by March 14, 2021, through the Federal eRulemaking Portal or via email. This is a request for information and does not involve a call for funding proposals or involve financial commitments from the government.

The Substance Abuse and Mental Health Services Administration (SAMHSA) is proposing a new tool called the SAMHSA Unified Client-Level Performance Reporting Tool (SUPRT) to streamline and improve how they collect data on mental health and substance use programs. This tool aims to reduce the burden on clients by allowing self-administered questionnaires and using administrative data from grantees. The SUPRT will help SAMHSA align its data collection with other federal agencies and improve its ability to monitor and evaluate the performance of its grant programs, contributing to broader public health goals. Public comments on this proposal can be submitted to the Office of Management and Budget by January 6, 2025.

The National Cancer Institute, part of the National Institutes of Health, is considering granting an exclusive patent license to Kyverna Therapeutics. This license would allow Kyverna to use certain patented inventions to develop a therapy using chimeric antigen receptors (CAR) targeting CD19 for treating autoimmune diseases. The CAR technology uses CRISPR/Cas9-edited T cells to recognize and attack cells expressing the CD19 protein, potentially offering a new treatment option for diseases such as lupus nephritis. Comments or objections to this proposed license must be submitted by March 5, 2021.

The National Cancer Institute, part of the National Institutes of Health, is considering granting an exclusive patent license to Kyverna Therapeutics for technology involving chimeric antigen receptors (CARs) that target the CD19 protein. This technology is aimed at creating a treatment for autoimmune diseases using a patient’s own altered T lymphocytes. The license could cover worldwide territories and would allow Kyverna to develop, produce, and market this therapy. Public comments or objections about the patent license need to be submitted by March 5, 2021.

The Department of Veterans Affairs (VA) is proposing a rule to exempt certain Whole Health well-being services from copayment requirements for Veterans. These services include education and skill-building programs, and complementary and integrative health services like yoga and meditation, provided within the VA Whole Health System of Care. By removing copayments, the aim is to encourage more Veterans to engage in these services, which focus on overall well-being rather than specific medical conditions. The public can submit their comments on this proposal by March 4, 2025.

The Center for Scientific Review Advisory Council is holding a public meeting on March 29, 2021, from 1:00 p.m. to 4:30 p.m. The meeting will be conducted virtually at the National Institutes of Health in Bethesda, MD, and aims to provide advice to the director of the Center for Scientific Review on various matters related to grant applications. Attendees can access the meeting online at https://videocast.nih.gov or visit https://public.csr.nih.gov/​AboutCSR/Organization/CSRAdvisoryCouncil for more information. For details or accommodations, individuals should contact Bruce Reed, Ph.D., the Deputy Director, at reedbr@mail.nih.gov.

The National Institutes of Health announced that a planned meeting originally scheduled for May 1-2, 2025, by the Center for Scientific Review Special Emphasis Panel has been canceled. This meeting was initially posted in the Federal Register on April 7, 2025. The cancellation notice was published on April 11, 2025, by Sterlyn H. Gibson, a Program Specialist at the Office of Federal Advisory Committee Policy.

The Bureau of the Fiscal Service in the Department of the Treasury announced new and increased fees for surety and reinsuring companies. These fees apply to various certifications and renewals, including those for Complementary, Alien, and Admitted Reinsurers. The changes, justified by the costs of analyzing company applications and financials, are set to become effective on January 1, 2025. This fee adjustment is supported by laws allowing the government to charge for specific services that benefit companies.

The Department of the Treasury, through the Bureau of the Fiscal Service, issued a notice correcting previous errors regarding fees for surety and reinsuring companies, as published in the Federal Register on December 2, 2024. The original document introduced new renewal fees for various types of reinsurers and increased existing fees, to be effective from January 1, 2025. Due to typographical errors affecting dollar amounts in the initial publication, corrections have now been issued, specifying the updated fee rates.